Bristol Myers Squibb Manufacturing Company recalls ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol
Recalled March 13, 2013 · FDA recall D-181-2013 · Bristol Myers Squibb Manufacturing
Hazard
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed. · FDA Class II
Units
21 blister packs
Sold at
LA, TN, CA
Description
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
Product
ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35
Manufacturer(s)
Bristol Myers Squibb Manufacturing Company
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →